| Revenue Information |
Note 10 – Revenue Information
Revenue by product lines was as follows:
| |
|
Three Months Ended |
|
|
Nine Months Ended |
|
| |
|
September 30, |
|
|
September 30, |
|
| Product Line |
|
2019 |
|
|
2018 |
|
|
2019 |
|
|
2018 |
|
| MicroParticle Catalyzed Biosensor (“MPC”) |
|
$ |
13,595 |
|
|
$ |
(18,798 |
) |
|
$ |
102,259 |
|
|
$ |
106,832 |
|
| Particle ImmunoFiltration Assay (“PIFA”) |
|
|
398,650 |
|
|
|
567,262 |
|
|
|
1,279,625 |
|
|
|
1,183,327 |
|
| Rapid Enzymatic Assay (“REA”) |
|
|
- |
|
|
|
- |
|
|
|
85,000 |
|
|
|
55,000 |
|
| Other |
|
|
8,567 |
|
|
|
8,625 |
|
|
|
30,564 |
|
|
|
41,006 |
|
| Total Revenue |
|
$ |
420,812 |
|
|
$ |
557,089 |
|
|
$ |
1,497,448 |
|
|
$ |
1,386,165 |
|
The total revenue by geographic area
determined based on the location of the customers was as follows:
| |
|
Three Months Ended |
|
|
Nine Months Ended |
|
| |
|
September 30, |
|
|
September 30, |
|
| Geographic Region |
|
2019 |
|
|
2018 |
|
|
2019 |
|
|
2018 |
|
| United States |
|
$ |
420,812 |
|
|
$ |
554,269 |
|
|
$ |
1,479,948 |
|
|
$ |
1,311,360 |
|
| Rest of World |
|
|
- |
|
|
|
2,820 |
|
|
|
17,500 |
|
|
|
74,805 |
|
| Total Revenue |
|
$ |
420,812 |
|
|
$ |
557,089 |
|
|
$ |
1,497,448 |
|
|
$ |
1,386,165 |
|
The Company had long-lived assets
totaling $11,461 and $14,294 located in the People’s Republic of China and $260,884 and $312,573 located in the United States
as of September 30, 2019 and December 31, 2018, respectively.
|